Levi Strauss & Co. (LEVI) – Corporate News Update
Trading Activity
- Current price: USD 20.93 per share on major U.S. exchanges.
- 24‑hour performance: Up 0.38 % as of 11:37 AM Central Europe on Thursday, 22 October 2026.
- Volume: Approximately USD 84.8 million worth of shares were traded in the last 24 hours.
- Shares outstanding: 383.7 million.
- Market capitalization: USD 8 billion.
Recent Performance
- Since the close of the previous month, the share price has increased by 4.34 %.
- The 200‑day simple moving average is USD 21.69.
- 52‑week range: Highest price of USD 25.70 recorded on 28 July 2026; lowest price of USD 17.72 recorded on 20 March 2026.
Comparable Stock Movements (last 24 hours)
| Symbol | Company | 24‑hour change | Current price (USD) | Market cap (USD bn) | P/E ratio |
|---|---|---|---|---|---|
| ORI | Old Republic | +1.13 % | 40.13 | 9.5 | 8.71 |
| DAR | Darling Ingredients | –0.22 % | 59.09 | 9.3 | 16.00 |
| KYMR | Kymera Therapeutics | –0.73 % | 112.63 | 9.4 | – |
| AEIS | Advanced Energy Industries | +3.30 % | 247.55 | 9.6 | 44.74 |
| HSIC | Henry Schein | +0.39 % | 85.01 | 9.4 | 24.56 |
Additional Corporate Information
- Headquarters: San Francisco, United States.
- Business focus: Manufacture and distribution of textiles, including jeans, casual pants, tops, jackets, shirts, and related apparel.
- Online presence: www.levistrauss.com .
- Exchange listing: New York Stock Exchange (NYSE).
Recent Product Development (Darling Ingredients)
Darling Ingredients Inc. announced the launch of Nextida NxCogni, a non‑stimulant collagen peptide intended to support cognitive clarity and resilience. The ingredient is part of the company’s Nextida platform and will undergo an initial open‑label human study in late 2026, followed by two large randomized controlled trials early in 2027. The product will be showcased at SupplySide Global in Las Vegas, where manufacturers can receive samples and additional information.
